Tower Research Capital LLC (TRC) - LUMOS PHARMA INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$6,376
+28.5%
1,932
+28.5%
0.00%
Q2 2023$4,960
+44990.9%
1,503
-53.2%
0.00%
Q1 2023$11
+10.0%
3,211
+14.8%
0.00%
Q4 2022$10
-100.0%
2,797
+8.3%
0.00%
Q3 2022$23,000
-11.5%
2,582
-21.3%
0.00%
-100.0%
Q2 2022$26,000
+2500.0%
3,280
+5025.0%
0.00%
Q1 2022$1,0000.0%64
-25.6%
0.00%
Q4 2021$1,00086
+8500.0%
0.00%
Q3 2021$0
-100.0%
1
-99.2%
0.00%
Q2 2021$1,000
-66.7%
123
-48.3%
0.00%
Q1 2021$3,000
-66.7%
238
-77.2%
0.00%
-100.0%
Q1 2020$9,0001,0430.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders